MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
Authors
Keywords
-
Journal
BLOOD
Volume 133, Issue 13, Pages 1507-1516
Publisher
American Society of Hematology
Online
2019-01-29
DOI
10.1182/blood-2018-10-880849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects
- (2018) Vidya Perera et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics
- (2017) Insaf Mohammad et al. PHARMACOTHERAPY
- Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
- (2016) Meir Preis et al. BLOOD
- Global Burden of Thrombosis: Table.
- (2016) Aaron M. Wendelboe et al. CIRCULATION RESEARCH
- Factor XIa–specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis
- (2016) Tovo David et al. Science Translational Medicine
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor XI as a target for antithrombotic therapy
- (2014) Charles E. Bane et al. DRUG DISCOVERY TODAY
- Dabigatran, bleeding, and the regulators
- (2014) T. J. Moore et al. BMJ-British Medical Journal
- Correlation of Missed Doses of Enoxaparin With Increased Incidence of Deep Vein Thrombosis in Trauma and General Surgery Patients
- (2014) Scott G. Louis et al. JAMA Surgery
- Congenital Factor XI Deficiency: An Update
- (2013) Stefano Duga et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation
- (2012) Pilar Gallego et al. Circulation-Arrhythmia and Electrophysiology
- Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery
- (2011) Anne Riddell et al. THROMBOSIS AND HAEMOSTASIS
- A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
- (2010) Q. Cheng et al. BLOOD
- Structure and function of factor XI
- (2010) J. Emsley et al. BLOOD
- Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
- (2010) Ophira Salomon et al. THROMBOSIS AND HAEMOSTASIS
- Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
- (2008) O. Salomon et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started